Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double‐Blind Randomized Controlled Trial
CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)
DOI: 10.1002/cns.70924 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 18.05.2026. Verfasst von Xuefei Jia und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Sugammadex, Neostigmine, Endarterectomy, Carotid, Anesthesia, General. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Carotid endarterectomy (CEA) is the standard treatment for carotid stenosis, but has the risk of cerebral hyperperfusion syndrome (CHS). Postoperative residual neuromuscular blockade can trigger cerebral hyperperfusion (CH), and the effects of neostigmine and sugammadex on cerebral perfusion during CEA are unclear.
Objective
This study aimed to compare the efficacy of neostigmine combined with atropine and sugammadex in reversing neuromuscular blockade in CEA patients under general anesthesia and evaluate the superiority of sugammadex in maintaining normal cerebral perfusion during anesthesia emergence.
Methods
A single‐center, prospective, randomized controlled study was carried out and registered on the Chinese Clinical Trial Registry website (ChiCTR2300078579). Between December 2023 and June 2024, 90 patients were recruited. After exclusions, 82 patients were randomly assigned to the sugammadex group or the neostigmine group at a 1:1 ratio. The primary outcome was the difference in the area under the curve of the percentage of middle cerebral artery velocity relative to baseline (MCAV% S) during emergence. Secondary outcomes included multiple hemodynamic and clinical parameters, as well as pulmonary and CH‐related complications within 48 h post‐operation. Mediation analysis, ROC analysis, and multivariate linear regression analysis were used to illustrate the differences in MCAV%S between the two groups and subsequent analysis.
Results
The MCAV% S in the sugammadex group was significantly lower than in the neostigmine group (24,600 [14,940–38,040] vs. 31,575 [24,210–50,040], p = 0.044), and this difference persisted after adjusting for variables (Estimate (95% CI): −10,896 [−21,387 ~ −405]; p = 0.042). The sugammadex group had shorter eye‐opening and extubation times, and a lower incidence of hypoxemia and overall pulmonary complication score. Mediation analysis showed that extubation time mediated part of the effect on MCAV% S, and the ROC analysis indicated good predictive performance of MCAV% S for CH.
Conclusion
In CEA patients, sugammadex is more advantageous than neostigmine in reversing neuromuscular blockade during emergence, as it shortens extubation time, reduces excessive cerebral blood flow, and potentially lowers the incidence of postoperative complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
- The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China.
- School of Reliability and Systems Engineering, Beihang University, Beijing, China.
- Science and Technology on Reliability and Environmental Engineering Laboratory, Beijing, China.
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, China.
ORCID-Profile: Tianlong Wang, Liqun Jiao, Xiaoyang Li, Lei Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jia, X., Cao, W., Li, T., Liu, Q., An, Y., Li, L., Li, Z., Liang, C., Wang, P., Song, H., Cui, K., Luo, M., Zhang, S., Chen, X., Wu, Z., Li, B., Wang, T., Jiao, L., Li, X., & Zhao, L. (2026). Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double‐Blind Randomized Controlled Trial. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70924
Vancouver
Jia X, Cao W, Li T, Liu Q, An Y, Li L, et al. Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double‐Blind Randomized Controlled Trial. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70924
BibTeX
@article{Jia2026,
author = {Jia, Xuefei and Cao, Wenbo and Li, Tianying and Liu, Qinghai and An, Yi and Li, Lixia and Li, Zhongjia and Liang, Chuanyu and Wang, Pei and Song, Hongyi and Cui, Ke and Luo, Manke and Zhang, Shuning and Chen, Xiaoxu and Wu, Zhiwei and Li, Boyuan and Wang, Tianlong and Jiao, Liqun and Li, Xiaoyang and Zhao, Lei},
title = {Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double‐Blind Randomized Controlled Trial},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {5},
doi = {10.1002/cns.70924}
}
EUVIMED